MWM
GILD icon

Merriman Wealth Management’s Gilead Sciences GILD Stock Holding History

Merriman Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,868
Closed -$911K – 161
2017
Q2 		$911K Sell
12,868
-13,950
-52% -$928K 0.25% 64
2017
Q1 		$1.82M Buy
26,818
+11
+0% +$773 0.44% 53
2016
Q4 		$1.92M Sell
26,807
-88
-0.3% -$6.54K 0.52% 46
2016
Q3 		$2.13M Buy
26,895
+12,502
+87% +$1.02M 0.44% 63
2016
Q2 		$1.2M Buy
+14,393
New +$1.28M 0.34% 68

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Merriman Wealth Management's GILD Position: Q3 2017 in Review

Merriman Wealth Management sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 12,868 shares — an estimated $911K sold.

Merriman Wealth Management first reported a position in GILD in Q2 2016 and held it in 5 quarters. The position peaked at $2.13M in Q3 2016. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Merriman Wealth Management reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • Merriman Wealth Management sold 12,868 Gilead Sciences shares in Q3 2017, an estimated $911K.
  • Merriman Wealth Management first reported a position in Gilead Sciences in Q2 2016 and held it in 5 quarters.
  • Merriman Wealth Management's Gilead Sciences position peaked at $2.13M in Q3 2016.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Merriman Wealth Management's 13F filing for Q3 2017, filed 19 Oct 2017.